FLU SHOTS WITH SQUALENE ON THE WAY FOR U.S.
This week, the Food and Drug Administration (FDA) published a study in the journal Science Translational Medicine, suggesting vaccines with squalene adjuvants may protect patients against even more types of flu viruses than they are being vaccinated against.
"MF59 adjuvant improves the immune response to a H5N1 vaccine by inducing qualitative and quantitative expansion of the antibody repertoires with protective potential," Hana Golding of the U.S. Food and Drug Administration and colleagues wrote.
COMMENT: Novartis and the FDA are setting things in place to approve flu shots with MF59 to be used in the US next year. The factory is built; they need a return on the investment. This is a looming disaster for Americans in the years to come.
And at the same time they are pushing shots with adjuvants in the US, Switzerland's medical regulator has recommended patients with serious autoimmune diseases to avoid H1N1 flu vaccines from Novartis, due to little research and high risk of autoimmune disease.